Recent ABCL Stock Price | ABCL Stock Predictions | |
$3.63 | +334.71% |
$15.78 |
Recent ABCL Analyst Ratings Breakdown, Making ABCL Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 10 | 10 | 10 | 9 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.2 |
For the ABCL stock predictions from the analysts covering AbCellera Biologics Inc, we have collected all of the individual ABCL stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering ABCL (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ABCL stock predictions may vary widely, another useful metric to consider is the median ABCL stock prediction, which represents the price at which half of the analysts
made ABCL stock predictions that were higher and half made ABCL stock predictions that were lower. This makes for a different take on the ABCL stock predictions out there, as compared to average or mean.
And that median across all the individual ABCL stock predictions was: $14.0 as of 2024-04-26.
The very highest of the ABCL stock predictions for one year price target was $28.0, while the very lowest of the ABCL stock predictions in the analyst group was
$8.0 (with a standard deviation of $7.013). Get the latest Zacks research report on ABCL — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
RST Stock Predictions
CSX Stock Predictions
BNS Stock Predictions
JD Stock Predictions
FARM Stock Predictions
WYNN Stock Predictions
INFU Stock Predictions
DOMO Stock Predictions
GES Stock Predictions
|
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |